1) Oktay MH, Smolkin MB, Williams M, Cajigas A. Metastatic anaplastic carcinoma of the thyroid mimicking squamous cell carcinoma: report of a case of a challenging cytologic diagnosis. Acta Cytol 2006;50:201-204.
2) Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453-464.
3) Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005; 103:1330-1335.
4) Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000;231:329- 338.
5) Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002;9:57-64.
6) Austin JR, el-Naggar AK, Goepfert H. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell. Otolaryngol Clin North Am 1996; 29:611-627.
7) Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66:321-330.
8) Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003;15:78-83.
9) Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control 2006;13:119-128.
10) Agrawal S, Rao RS, Parikh DM, Parikh HK, Borges AM, Sampat MB. Histologic trends in thyroid cancer 1969-1993: a clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J Surg Oncol 1996;63:251-255.
11) Ibanez ML, Russell WO, Albores-Saavedra J, Lampertico P, White EC, Clark RL. Thyroid carcinoma biologic behavior and mortality. Postmortem findings in 42 cases, including 27 in which the disease was fatal. Cancer 1966;19:1039-1052.
12) Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants. Endocr Pathol 2005;16:323-330.
13) Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002;131:245-248.
14) Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973- 1991. Cancer1997;79:564-573.
15) Nix PA, Nicolaides A, Coatesworth AP. Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer. Int J Clin Pract 2006;60:80-84.
16) McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, et al. Anaplastic Thyroid Carcinoma: 50 year experience at a single institution. Surgery 2001;130:1028-1034.
17) Fortson JK, Durden FL Jr, Patel V, Darkeh A. The coexistence of anaplastic and papillary carcinomas of the thyroid: a case presentation and literature review. Am Surg 2004;70:1116-1119.
18) Silver RJ, Parangi S. Management of thyroid incidentalomas. Surg Clin North Am 2004;84:907-919.
19) Nishiyama RH, Dunn EL, Thompson NW. Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer 1972;30:113-127.
20) Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Nikiforov YE, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399-5404.
21) Luis A. Pacheco-Ojeda, Ana L Martinez, Marcelo Alverez. Anaplastic Thyroid carcinoma. Analysis of prognostic factors. Int Surg 2001;86:117-121.
22) Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991;110:956-961; discussion 961-963.
23) Stoler DL, Datta RV, Charles MA, Block AW, Brenner BM, Sieczka EM, et al. Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck 2002;24:290-295.
24) Sniezek JC, Holtel M. Rare tumors of the thyroid gland. Otolaryngol Clin North Am 2003;36:107-115.
25) Wallin G, Backdahl M, Tallroth Ekman E, Lundell G. Co-existent anaplastic and well differantiated thyroid carcinomas: A nuclear DNA study. Eur J Surg Oncol 1989;15:43-48.
26) Galer Davidson H, Bibbo M, Dytch HE, Gonzolez- Campore R, Fernandez A, Wied GL. Nuclear DNA in anaplastic thyroid carcinoma with a differentiated component. Histopathology 1987;11:715-722.
27) Giuffrida D, Gharib Gharib D. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000;11:1083-1089.